Generic Liraglutide: Available Now Generic liraglutide became available in 2024, offering patients an FDA-approved alternative in the same GLP-1 drug class as semaglutide
Results for Study 3 At the end of the 12-week intensive lifestyle intervention lead-in, for patients who subsequently entered the randomized treatment period (n=579), the average body weight loss due to lifestyle was 6.9% (Week -12 to Week 0)
10.4158/EP13076.LT 93
The biology offers a plausible foundation
Kadrnka F
do not use if you have a history of severe gastrointestinal disease Signs of low blood sugar (for example, dizziness, weakness, shakiness, jitteriness, headache, anxiety/mood changes, rapid heartbeat, confusion, slurred speech, sweating, or lightheadedness)